Testing a fast-acting medication for severe agitation in teens with bipolar disorder or schizophrenia

This trial is testing BXCL501, a new medication that dissolves under the tongue to quickly calm severe agitation in teenagers with bipolar disorder or schizophrenia. Researchers want to find out if this treatment works better than a placebo (a dummy film with no medicine) and whether it's safe. The medication is tested at different doses to see which works best.

Severe agitation in teenagers with bipolar disorder or schizophrenia can be dangerous and distressing, but current treatment options may not work fast enough. This trial exists to see if this new medication could provide quicker relief during a crisis.